Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Neuralgia 2Neoplasms 2Lung Neoplasms 2Leiomyoma 2Sexual Dysfunction, Physiological 1Scleroderma, Localized 1Pneumonia 1Pain 1Neuropathy, Painful 1Neurofibromatoses 1Neurodermatitis 1Neoplasms, Cystic, Mucinous, and Serous 1Mastodynia 1Lymphoma, Follicular 1Lichen Planus 1Leukemia-Lymphoma 1Kidney Neoplasms 1Keratoacanthoma 1Keloid 1Ileus 1Hydrocephalus 1Hordeolum 1Headache 1Granuloma Annulare 1Eyelid Neoplasms 1Epilepsy 1Dermoid Cyst 1Colorectal Neoplasms 1Cold Hypersensitivity 1

Interventions

nabiximols 7Morphine 7Fentanyl 7Hydromorphone 6Tapentadol 5Radiotherapy 4Prednisone 3Methadone 3Ketamine 3Duloxetine Hydrochloride 3Calcium Dobesilate 3Calcium 3Analgesia 3Acetaminophen 3cabozantinib 2Zoledronic Acid 2Surveys and Questionnaires 2Sugars 2Radiosurgery 2Pregabalin 2Pain Management 2Oxycodone 2Minocycline 2Letrozole 2Ibuprofen 2Diclofenac 2Dexamethasone 2Cryosurgery 2Calcium Gluconate 2Bupivacaine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pain × Lidocaine × Clear all
NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed
33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡